Study shows how MS patients treated with Rituximab react to COVID-19 vaccination
MS patients treated with Rituximab have better responses to the COVID-19 vaccine if they have higher B cell counts.
Source: news-medical.net
Stay updated with breaking news from Anna Wiberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MS patients treated with Rituximab have better responses to the COVID-19 vaccine if they have higher B cell counts.